Can a phone app and mindfulness keep chemo patients moving?
NCT ID NCT07819045
First seen Sep 14, 2026 · Last updated Sep 18, 2026 · Updated 3 times
Summary
Researchers at the University of Oklahoma are testing a mobile health program designed to help adults receiving chemotherapy for metastatic breast or gynecologic cancer stay physically active. The program combines a wearable activity tracker, behavior change techniques, acceptance and mindfulness training, and a social feature where participants share responses to weekly challenges. The study enrolls 42 people who are starting chemotherapy and measures whether the program is easy to use, useful, enjoyable, and feasible to complete.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a mobile health program combining a wearable activity tracker, acceptance and mindfulness training, and social support
- What this could lead to
- If it works, this approach could give people on chemotherapy a practical, phone-based way to stay active and protect their quality of life during treatment.
- What could go wrong
- This is a small proof-of-concept study of 42 people, so it can only show whether the program is usable and well liked, not whether it improves health. Participants may find the program hard to keep up with while managing chemotherapy side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
42 people
The number who actually took part.
- Started
-
Sep 2025
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Having ever received a histologically confirmed diagnosis of invasive breast or gynecologic carcinoma (eligible cancer types include epithelial ovarian carcinoma, endometrial/uterine carcinoma, and invasive cervical carcinoma; other rare gynecologic malignancies \[e.g., vaginal, vulvar\] may also be included if explicitly approved by the study team) * Scheduled to receive cytotoxic chemotherapy for a minimum of 4 consecutive weeks but not yet begun or are within 4 weeks of having started their chemotherapy for cancer * Ability to speak and read English * Having internet access * Being willing and able to use a smartphone and web interface with or without assistance. If assistance is needed, it must be readily available * Adequate visual and hearing acuity to use a smartphone and web interface as indicated by self-report * Adequate motor capacity to use a smartphone and web interface as indicated by self-report * Willingness to download and use study-specific app(s), the Fitbit mobile application (this requires use of a Google Gmail account), and other mobile applications for study purposes Exclusion criteria: * Eastern Cooperative Oncology Group test score \> 2 * Having unstable bone metastases * Untreated brain metastases * Contraindications to physical activity (e.g., uncontrolled hypertension or cardiac disease) * Having a body mass index under 18 * Major psychiatric conditions such as bipolar disorder, psychosis, schizophrenia, or alcoholism that could affect the ability to understand and/or complete the study * Having arthritic or orthopedic issues that would preclude physical exercise * Another member of the household is a primary participant or staff member on this trial * Being a prisoner * Living in an assisted living facility or nursing home * Enrolled in hospice
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Metastatic invasive breast cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
TSET Health Promotion Research Center, Oklahoma City, Oklahoma 73104
Oklahoma City, Oklahoma, 73104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test reveal hidden breast cancer spread?
- Can a drug that blocks HER proteins re-sensitize resistant breast cancer to hormone therapy?
- Blood test could signal when to switch breast cancer therapy before tumors grow
- Blood markers may reveal hormone therapy success in breast cancer
- Mindfulness and movement: new program aims to ease fatigue in advanced breast cancer